TERAGNI, CRISTINA MARIA
TERAGNI, CRISTINA MARIA
Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study
2022-01-01 Quaquarini, Erica; Sottotetti, Federico; Agustoni, Francesco; Pozzi, Emma; Malovini, Alberto; Teragni, Cristina Maria; Palumbo, Raffaella; Saltalamacchia, Giuseppe; Tagliaferri, Barbara; Balletti, Emanuela; Rinaldi, Pietro; Canino, Costanza; Pedrazzoli, Paolo; Bernardo, Antonio
Impact of COVID-19 outbreak on cancer patient care and treatment: Data from an outpatient oncology clinic in Lombardy (Italy)
2020-01-01 Quaquarini, E.; Saltalamacchia, G.; Presti, D.; Caldana, G.; Tibollo, V.; Malovini, A.; Palumbo, R.; Teragni, C. M.; Balletti, E.; Mollica, L.; Biscaldi, E.; Frascaroli, M.; Bernardo, A.; Sottotetti, F.
Nanoparticle albumin-bound paclitaxel (Nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: Prospective evaluation of activity, safety, and quality of life
2015-01-01 Palumbo, R.; Sottotetti, F.; Trifiro, G.; Piazza, E.; Ferzi, A.; Gambaro, A.; Spinapolice, E. G.; Pozzi, E.; Tagliaferri, B.; Teragni, C.; Bernardo, A.
Nivolumab induced thyroid dysfunction: Unusual clinical presentation and challenging diagnosis
2019-01-01 Iadarola, C.; Croce, L.; Quaquarini, E.; Teragni, C.; Pinto, S.; Bernardo, A.; Fonte, R.; Marino, M.; Rotondi, M.; Chiovato, L.
Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience
2019-01-01 Palumbo, R.; Sottotetti, F.; Quaquarini, E.; Gambaro, A.; Ferzi, A.; Tagliaferri, B.; Teragni, C.; Licata, L.; Serra, F.; Lapidari, P.; Bernardo, A.
Renal cell carcinoma and malignant peritoneal mesothelioma after occupational asbestos exposure: case report
2016-01-01 Candura, Stefano; Boeri, Riccardo; Teragni, CRISTINA MARIA; Chen, Yao; Scafa, Fabrizio
Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer
2020-01-01 Tagliaferri, B.; Quaquarini, E.; Palumbo, R.; Balletti, E.; Presti, D.; Malovini, A.; Agozzino, M.; Teragni, C. M.; Terzoni, A.; Bernardo, A.; Villani, L.; Sottotetti, F.
Vinflunine in Advanced Transitional Cell Cancer of the Urothelial Tract: A Potential Option for Maintenance Therapy? A Case Series
2018-01-01 Palumbo, R.; Licata, L.; Sottotetti, F.; Tagliaferri, B.; Pozzi, E.; Teragni, C.; Quaquarini, E.; Bernardo, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Clinical and Biological Variables Influencing Outcome in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Anti-PD-1/PD-L1 Antibodies: A Prospective Multicentre Study | 1-gen-2022 | Quaquarini, Erica; Sottotetti, Federico; Agustoni, Francesco; Pozzi, Emma; Malovini, Alberto; Teragni, Cristina Maria; Palumbo, Raffaella; Saltalamacchia, Giuseppe; Tagliaferri, Barbara; Balletti, Emanuela; Rinaldi, Pietro; Canino, Costanza; Pedrazzoli, Paolo; Bernardo, Antonio | |
| Impact of COVID-19 outbreak on cancer patient care and treatment: Data from an outpatient oncology clinic in Lombardy (Italy) | 1-gen-2020 | Quaquarini, E.; Saltalamacchia, G.; Presti, D.; Caldana, G.; Tibollo, V.; Malovini, A.; Palumbo, R.; Teragni, C. M.; Balletti, E.; Mollica, L.; Biscaldi, E.; Frascaroli, M.; Bernardo, A.; Sottotetti, F. | |
| Nanoparticle albumin-bound paclitaxel (Nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: Prospective evaluation of activity, safety, and quality of life | 1-gen-2015 | Palumbo, R.; Sottotetti, F.; Trifiro, G.; Piazza, E.; Ferzi, A.; Gambaro, A.; Spinapolice, E. G.; Pozzi, E.; Tagliaferri, B.; Teragni, C.; Bernardo, A. | |
| Nivolumab induced thyroid dysfunction: Unusual clinical presentation and challenging diagnosis | 1-gen-2019 | Iadarola, C.; Croce, L.; Quaquarini, E.; Teragni, C.; Pinto, S.; Bernardo, A.; Fonte, R.; Marino, M.; Rotondi, M.; Chiovato, L. | |
| Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience | 1-gen-2019 | Palumbo, R.; Sottotetti, F.; Quaquarini, E.; Gambaro, A.; Ferzi, A.; Tagliaferri, B.; Teragni, C.; Licata, L.; Serra, F.; Lapidari, P.; Bernardo, A. | |
| Renal cell carcinoma and malignant peritoneal mesothelioma after occupational asbestos exposure: case report | 1-gen-2016 | Candura, Stefano; Boeri, Riccardo; Teragni, CRISTINA MARIA; Chen, Yao; Scafa, Fabrizio | |
| Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer | 1-gen-2020 | Tagliaferri, B.; Quaquarini, E.; Palumbo, R.; Balletti, E.; Presti, D.; Malovini, A.; Agozzino, M.; Teragni, C. M.; Terzoni, A.; Bernardo, A.; Villani, L.; Sottotetti, F. | |
| Vinflunine in Advanced Transitional Cell Cancer of the Urothelial Tract: A Potential Option for Maintenance Therapy? A Case Series | 1-gen-2018 | Palumbo, R.; Licata, L.; Sottotetti, F.; Tagliaferri, B.; Pozzi, E.; Teragni, C.; Quaquarini, E.; Bernardo, A. |